Blood cancers, Myeloma
Results
Phase 2
This trial looked at giving bendamustine chemotherapy with thalidomide and dexamethasone. The trial was for people who had already had treatment for myeloma, but it had come back (recurred).
Recruitment start: 27 January 2011
Recruitment end: 27 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Steve Schey
Myeloma UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Leeds
Last reviewed: 24 August 2015
CRUK internal database number: 7606
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
